Yi Ba

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Top Venues

Cancer biology & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Feixue Wang, Yi Ba
Treatment strategies for patients with HER2-positive gastric cancer. Cancer biology & medicine 20 (12) (2024)
Tao Ning, Danyang Li, Ting Deng, Yuxian Bai, Ye Chen, Zhiyu Wang, Bin Hu, Yi Ba, Wei Lu
Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study. Cancer (2024)
Feixue Wang, Yi Ba
Treatment strategies for patients with HER2-positive gastric cancer. Cancer biology & medicine 20 (12) (2024)
Tao Ning, Danyang Li, Ting Deng, Yuxian Bai, Ye Chen, Zhiyu Wang, Bin Hu, Yi Ba, Wei Lu
Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study. Cancer 130 (18) (2024)
Feixue Wang, Yi Ba
Treatment strategies for patients with HER2-positive gastric cancer. Cancer biology & medicine 20 (12) (2024)
Feixue Wang, Yi Ba
Erratum to Treatment strategies for patients with HER2-positive gastric cancer. Cancer biology & medicine 21 (3) (2024)
Feixue Wang, Yi Ba
Erratum to Treatment strategies for patients with HER2-positive gastric cancer. Cancer biology & medicine 21 (3) (2024)
Tao Ning, Danyang Li, Ting Deng, Yuxian Bai, Ye Chen, Zhiyu Wang, Bin Hu, Yi Ba, Wei Lu
Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study. Cancer 130 (18) (2024)
Tao Ning, Danyang Li, Ting Deng, Yuxian Bai, Ye Chen, Zhiyu Wang, Bin Hu, Yi Ba, Wei Lu
Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study. Cancer 130 (18) (2024)
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie, Yi Ba
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer. Cancer biology & medicine 21 (7) (2024)
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie, Yi Ba
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer. Cancer biology & medicine 21 (7) (2024)
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie, Yi Ba
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer. Cancer biology & medicine 21 (7) (2024)
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie, Yi Ba
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer. Cancer biology & medicine (2023)
Le Zhang, Rui Liu, Ting Deng, Yi Ba
Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022. Cancer innovation 2 (1) (2023)
Ying Liu, Meng Wang, Ting Deng, Rui Liu, Tao Ning, Ming Bai, Guoguang Ying, Haiyang Zhang, Yi Ba
Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation <i>via</i> C/EPBβ. Cancer biology & medicine 19 (9) (2022)
Qiumo Zhang, Ting Deng, Hongdian Zhang, Duo Zuo, Qihang Zhu, Ming Bai, Rui Liu, Tao Ning, Le Zhang, Zhentao Yu, Haiyang Zhang, Yi Ba
Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (28) (2022)
Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie, Yi Ba
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma. Cancer biology & medicine (2022)
Hanhan Ning, Shan Huang, Yang Lei, Renyong Zhi, Han Yan, Jiaxing Jin, Zhenyu Hu, Kaimin Guo, Jinhua Liu, Jie Yang, Zhe Liu, Yi Ba, Xin Gao, Deqing Hu
Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity. Nature communications 13 (1) (2022)
Xinyi Wang, Haiyang Zhang, Shengjie Yin, Yuchong Yang, Haiou Yang, Jiayu Yang, Zhengyang Zhou, Shuang Li, Guoguang Ying, Yi Ba
lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin. EMBO reports (2021)
Haiyang Zhang, Meng Wang, Yi He, Ting Deng, Rui Liu, Weixue Wang, Kegan Zhu, Ming Bai, Tao Ning, Haiou Yang, Ying Liu, Junyi Wang, Yi Ba
Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells. Cell death & disease 12 (12) (2021)
Huiya Wang, Xia Wang, Haiyang Zhang, Ting Deng, Rui Liu, Ying Liu, Hongli Li, Ming Bai, Tao Ning, Junyi Wang, Shaohua Ge, Yi Ba
The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Oncogene 40 (28) (2021)
Zhi Peng, Tianshu Liu, Jia Wei, Airong Wang, Yifu He, Liuzhong Yang, Xizhi Zhang, Nanfeng Fan, Suxia Luo, Zhen Li, Kangsheng Gu, Jianwei Lu, Jianming Xu, Qingxia Fan, Ruihua Xu, Liangming Zhang, Enxiao Li, Yuping Sun, Guohua Yu, Chunmei Bai, Yong Liu, Jiangzheng Zeng, Jieer Ying, Xinjun Liang, Nong Xu, Chao Gao, Yongqian Shu, Dong Ma, Guanghai Dai, Shengmian Li, Ting Deng, Yuehong Cui, Jianmin Fang, Yi Ba, Lin Shen
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study. Cancer communications (London, England) 41 (11) (2021)
Yi Ba, Yuan-Kai Shi, Wenqi Jiang, Jifeng Feng, Ying Cheng, Li Xiao, Qingyuan Zhang, Wensheng Qiu, Binghe Xu, Ruihua Xu, Bo Shen, Zhiguo Luo, Xiaodong Xie, Jianhua Chang, Mengzhao Wang, Yufu Li, Yuerong Shuang, Zuoxing Niu, Bo Liu, Jun Zhang, Li Zhang, Herui Yao, Conghua Xie, Huiqiang Huang, Wangjun Liao, Gongyan Chen, Xiaotian Zhang, Hanxiang An, Yanhong Deng, Ping Gong, Jianping Xiong, Qinghua Yao, Xin An, Cheng Chen, Yanxia Shi, Jialei Wang, Xiaohua Wang, Zhiqiang Wang, Puyuan Xing, Sheng Yang, Chenfei Zhou
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association. Cancer biology & medicine 17 (4) (2020)
Ming Bai, Peiyun Wang, Jiayu Yang, Mengsi Zuo, Yi Ba
Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer. Journal of physiology and biochemistry 76 (4) (2020)
Haiyang Zhang, Ting Deng, Rui Liu, Tao Ning, Haiou Yang, Dongying Liu, Qiumo Zhang, Dan Lin, Shaohua Ge, Ming Bai, Xinyi Wang, Le Zhang, Hongli Li, Yuchong Yang, Zhi Ji, Hailong Wang, Guoguang Ying, Yi Ba
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Molecular cancer 19 (1) (2020)
Aisen Zhang, Cheng Wang, Hui Lu, Xi Chen, Yi Ba, Chunni Zhang, Chen-Yu Zhang
Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules. Disease markers 2019 (2019)
Yajing Qu, Haiyang Zhang, Wu Sun, Yueting Han, Shuang Li, Yanjun Qu, Guoguang Ying, Yi Ba
MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2. Cancer science 109 (3) (2018)
Haiyang Zhang, Yi Wang, Ming Bai, Junyi Wang, Kegan Zhu, Rui Liu, Shaohua Ge, JiaLu Li, Tao Ning, Ting Deng, Qian Fan, Hongli Li, Wu Sun, Guoguang Ying, Yi Ba
Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer science 109 (3) (2018)